Article info

Download PDFPDF
The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment

Authors

  1. Correspondence to Dr Simon John Whitehead, Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands WV10 0QP, UK; simonwhitehead{at}nhs.net
View Full Text

Citation

Whitehead SJ, Ford C, Gama R
The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment

Publication history

  • Received December 16, 2013
  • Revised February 3, 2014
  • Accepted February 12, 2014
  • First published April 7, 2014.
Online issue publication 
May 17, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.